Interestingly, in rectal adenocarcinoma, a combination of CD39 and CD73 expression provided better prognostic value, with CD73hiCD39lo and CD73loCD39hi tumors showing worse and best outcomes, respectively [85]. The gene discussed is ENTPD1; the disease is rectum adenocarcinoma.